Ypsomed Holding AG | Ownership
Companies that own Ypsomed Holding AG
Norges Bank Investment Management
168,356
1.33%
86,744
0%
12/31/2017
GAM Investment Management (Switzerland) AG
96,555
0.76%
-168
0.22%
05/31/2018
The Vanguard Group, Inc.
79,890
0.63%
1,746
0%
07/31/2018
VV Vermögensverwaltung AG
45,000
0.36%
0
0.92%
06/29/2018
UBS AG (Investment Management)
37,334
0.3%
3,000
0%
09/04/2018
BlackRock Fund Advisors
36,629
0.28%
0
0%
09/06/2018
Credit Suisse Asset Management (Schweiz) AG
36,345
0.28%
-8,306
0.01%
05/31/2018
Dimensional Fund Advisors LP
36,170
0.28%
5,047
0%
04/30/2018
Zürcher Kantonalbank (Investment Management)
32,812
0.26%
1,569
0.01%
07/31/2018
EFG Asset Management (UK) Ltd.
27,000
0.21%
1,500
0.61%
04/30/2018
| Address |
Brunnmattstrasse 6
Burgdorf Bern (Berne) 3401
Switzerland
|
|
Employees
|
- |
| Website |
http://www.ypsomed.com |
| Updated |
07/08/2019 |
| Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. Its products include DiaExpert, BGMS, OmniPod, YpsoPump & Orbit, Pen needles, Injection systems, and Contract manufacturing. The company operates through the following business segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems. |
